XML 40 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stockholders’ Equity (Tables)
 12 Months Ended
Jun. 30, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of option activity
                    
       Weighted-Average     
       Exercise   Remaining   Aggregate 
   Number of   Price   Contractual   Intrinsic 
   Shares   Per Share   Term   Value 
   (In thousands)       (In years)   (In thousands) 
Balance of options outstanding at June 30, 2021   1,697   $2.98           
Options granted   111    5.65           
Options forfeited   (1)   3.13           
Options expired   (16)   2.17           
Options exercised   (408)   2.29           
Balance of options outstanding at June 30, 2022   1,383   $3.40    3.6   $2,763 
Options exercisable at June 30, 2022   1,050   $3.09    3.3   $2,414 
Summary of option grant-date fair value and intrinsic value information
          
   Years Ended June 30, 
   2022   2021 
   (In thousands, 
   except per share data) 
Weighted-average grant date fair value per share  $2.94   $2.84 
Intrinsic value of options exercised  $1,506   $1,110 
Summary of other-than-option activity
          
   Number of Shares   Weighted-Average Grant Date Fair Value per Share 
   (In thousands)     
Balance of RSUs outstanding at June 30, 2021   918   $4.14 
Granted   701    6.59 
Forfeited   (52)   4.81 
Vested   (452)   4.45 
Balance of RSUs outstanding at June 30, 2022   1,115   $5.50 
Schedule of share-based compensation expense by functional line item
          
   Years Ended June 30, 
   2022   2021 
   (In thousands) 
Cost of revenues  $369   $281 
Selling, general and administrative   4,862    2,719 
Research and development   1,015    584 
Total share-based compensation expense  $6,246   $3,584 
Schedule of unrecognized share-based compensation expense
          
   Remaining Unrecognized Compensation Expense   Remaining Weighted-Average Years to Recognize 
   (In thousands)     
Stock options  $650    1.6 
RSUs   5,267    2.6 
PSUs   1,077    1.5 
Common stock purchase rights under ESPP   129    0.4 
   $7,123      
Equity Option [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Valuation Assumptions
          
   Years Ended June 30, 
   2022   2021 
Expected term (in years)   4.7    7.0 
Expected volatility   63%    69% 
Risk-free interest rate   0.82%    0.59% 
Dividend yield   0.00%    0.00% 
Performance Shares [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of other-than-option activity
     
   Number of Shares 
   (In thousands) 
Balance of PSUs outstanding at June 30, 2021   1,084 
Granted   575 
Vested   (629)
Balance of PSUs outstanding at June 30, 2022   1,030 
Employee Stock [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Valuation Assumptions
          
   Years Ended June 30, 
   2022   2021 
Expected term (in years)   0.5    0.5 
Expected volatility   59%    62% 
Risk-free interest rate   0.92%    0.08% 
Dividend yield   0.00%    0.00% 
Summary of other-than-option activity
     
   Year Ended 
   June 30, 2022 
   (In thousands, except per share data) 
Shares available for issuance at June 30, 2021   250 
Shares issued   (165)
Shares available for issuance at June 30, 2022   85 
Weighted-average purchase price per share  $4.62 
Intrinsic value of ESPP shares on purchase date  $378